However, when combined with insulin or sulphonylureas, the risk increases significantly
Semaglutide Study Finds Link to Blood Clots A 2021 study published in the Endocrine Journal (Volume 68, Issue 6, pages 739-742) found that type 2 diabetes patients using semaglutide were at a 266% increased risk of deep vein thrombosis
The cases herein, to our knowledge, are the first to demonstrate potential mental health benefits of tirzepatide, a GLP-1/GIP receptor agonist
This appetite-suppressing effect can be helpful for managing weight and improving blood sugar levels in people with type 2 diabetes
Based on what we know so far, the medication itself does not appear to meaningfully transfer into milk
Although more research is still required, concentrating on a single component may divert attention from the most important factors for long-term health